SCHEMBL2491086

SCHEMBL2491086

Nc1nc(Cc2n[nH]c(N)n2)n[nH]1

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
GAA P10253 4/20 0.33
GFER P55789 2/20 0.33
RECQL P46063 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7750625 0.79
SCHEMBL8660213 0.79 CASP1 (0.39) ALPLSMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL1464442 0.79
SCHEMBL8656235 0.79 CASP1 (0.44) ALPLSMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL4471709 0.79
SCHEMBL960185 0.79 LTB4R (0.49) LMNAALDH1A1MAPTGAAGFER
SCHEMBL758183 0.77
SCHEMBL8658631 0.77 ALDH1A1 (0.39) ALPLSMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL4457413 0.75
SCHEMBL11012295 0.74 ALPL (0.48) ALPLSMN1; SMN2LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722199-A1 AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2026-04-08 EP disclosed
US-20250215572-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY SHIKOKU CHEMICALS CORPORATION (JP) 2025-07-03 US disclosed
US-20250206764-A1 TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2025-06-26 US disclosed
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
EP-4501937-A1 TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF Shikoku Chemicals Corporation (JP) 2025-02-05 EP disclosed
WO-2024247919-A1 AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF 四国化成工業株式会社 2024-12-05 WO disclosed
CN-118922427-A Triazole compound, synthesis method of triazole compound, coupling agent and application thereof 四国化成工业株式会社 2024-11-08 CN disclosed
CN-118922584-A Surface treating agent for copper or copper alloy 四国化成工业株式会社 2024-11-08 CN disclosed
WO-2024005117-A1 SURFACE TREATMENT AGENT FOR METAL CORD AND USE OF SAID SURFACE TREATMENT AGENT 四国化成工業株式会社 2024-01-04 WO disclosed
WO-2023190264-A1 TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF 四国化成工業株式会社 2023-10-05 WO disclosed
WO-2023190263-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY 四国化成工業株式会社 2023-10-05 WO disclosed
EP-4182325-A1 PHOSPHORAMIDITE SYNTHESIS ON-DEMAND Aarhus Universitet (DK) 2023-05-24 EP disclosed
CN-105037403-B Coordination polymer porous material MAF-49, preparation method therefor and application thereof 中山大学 2017-04-19 CN disclosed
CN-105037403-A Coordination polymer porous material MAF-49, preparation method therefor and application thereof UNIV SUN YAT SEN 2015-11-11 CN disclosed
US-8330039-B2 Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-11 US disclosed
EP-2380208-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. du Pont de Nemours and Company (US) 2011-10-26 EP disclosed
WO-2010085664-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-07-29 WO disclosed
US-20100180947-A1 SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206764-A1 TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF CYP51A1, CYP3A5, NAT1 ALPL 3410/4885SMN1; SMN2 4854/4885LMNA 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.